Roche, GSK melanoma pill combinations look similar in showdown

September 29, 2014 1:56 PM

6 0

Roche, GSK melanoma pill combinations look similar in showdown

MADRID (Reuters) - Rival two-pill combinations for melanoma from Roche and GlaxoSmithKline had similarly good results in separate clinical trials, leaving doctors with little to choose between the two skin cancer courses.

The latest findings will fuel a wider debate about the optimal treatment of melanoma as a new generation of immune-stimulating injections offers an alternative way to fight the deadliest form of skin cancer.

Read more

To category page

Loading...